How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code PFX: System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection. View classification details, related manufacturers, 510(k) clearances, and recall records.
A microarray-based, genome-wide, postnatal chromosomal abnormality detection system is used to qualitatively detect constitutional gains and losses in chromosomal copy numbers across the human genome using microarray methods. It is intended as an aid in the postnatal diagnosis of developmental delay and/or intellectual disability (DD/ID), congenital anomalies, and dysmorphic features in conjunction with other clinical information currently used in postnatal diagnosis. It is not intended to be used for standalone diagnostic purposes, prenatal or pre-implantation testing or screening, population screening, or for the detection of, or screening for, acquired or somatic genetic aberrations.Explore immunology records →
1 clearance records and 2 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Apr 14, 2016 to Mar 20, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| PFX · System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection | 1 | 2 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| GenetiSure Dx Labeling Kit, REF: K1201-64105, contains human reference DNA female aliquot, REF5190-7317. A required kit for the GenetiSure Dx Pos…Z-1544-2025 · PFX | Agilent Technologies, Inc. | Recall | Apr 8, 2025FDA classification date |
| GenetiSure Dx Postnatal AssayK163367 · PFX | Agilent Technologies, Inc. | 510(k) | Aug 11, 2017FDA decision date |
| CytoScan Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software. The CytoSc…Z-1909-2016 · PFX | Affymetrix Inc | Recall | Jun 3, 2016FDA record creation date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.